Abstract 312: Enhanced Systemic Inflammation Accelerates Plaque Reduction Following Lipid Lowering Therapy in Mice

Introduction: Antibody therapies targeting inflammatory markers such as TNFα (adalimumab) and IL-1β (canakinumab) reportedly reduce the risk of cardiovascular disease (CVD). However, the use of ant...